KNOW Bio Announces Acquisition of Clinical Sensors, Inc.

Nitric oxide release technology will have broad applications for unmet needs in diabetic health management

Durham, N.C., December 19, 2019 /PRNewswire/ — KNOW Bio, LLC., (“KNOW Bio” or the “Company”), a North Carolina developer of nitric oxide-based medical technology and related biotechnology companies, announced today that the Company has acquired Clinical Sensors, Inc, (“Clinical Sensors”) to develop the Company’s technology in the field of diabetes management. Immediately after the acquisition, Clinical Sensors was renamed Diabetic Health, Inc. (“DHI”).